Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Tatva Chintan Pharma Chem Ltd

NSE: TATVA · BSE: 543321 · Chemicals & Petrochemicals · 9 announcements

Share price
₹1,793.20
Market cap
₹4,195 Cr
Revenue (annual)
₹505.9 Cr
Net profit (annual)
₹42.05 Cr
P/E (TTM)
81.6×Sector 37.5×
Promoter holding
72.02%+0.00% QoQ
FII holding
3.93%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

Time

2 announcements with these filters

19:10 IST NSE
Annual General Meeting

Tatva Chintan Pharma Chem Annual General Meeting

The company held its 30th Annual General Meeting on September 25, 2026. Shareholders considered and approved items including financial statements and director re-appointments.

17:16 IST NSE
Credit Rating

Tatva Chintan Pharma Chem Credit Rating

CRISIL Ratings upgraded Tatva Chintan's long-term bank facilities to CRISIL A-/Stable and short-term facilities to CRISIL A2+. This upgrade reflects the company's improved credit profile.